Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[Altitrade Partners]

As excited as we are about the prospects for CRXM, we would caution investors not to get too far ahead of themselves.

There is still a lot of work that needs to take place before this company is out of the woods, and we can sound the "all clear".

Yes, they are making progress, albeit slowly.

Getting FDA approval is still a long road from here.

Let's try to keep things in perspective.

https://seekingalpha.com/instablog/22758161-altitrade-partners/5571234-potential-billion-dollar-heart-drug-catapult-shares-of-gene-biotherapeutics-much-higher